Bio Pharma Dive
MARCH 20, 2023
In documents released Monday, agency staff appeared inclined to approve Biogen’s tofersen, which failed in its main trial. Gathering confirmatory evidence of its benefit could be difficult, however.
Pharmaceutical Technology
MARCH 20, 2023
BioNTech has signed an exclusive worldwide licence and collaboration agreement with OncoC4 to co-develop and commercialise a new checkpoint antibody in multiple solid tumour indications. Under the deal, the two companies will co-develop OncoC4’s ONC-392, an anti-CTLA-4 monoclonal antibody candidate, as a monotherapy or as a combination therapy with anti-PD-(L)-1 antibodies in several solid tumour indications, including NSCLC.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
MARCH 20, 2023
The results add to a growing body of evidence that Karuna’s drug, known as KarXT, could be a valuable new option for patients living with the brain disorder.
Pharmaceutical Technology
MARCH 20, 2023
RVAC Medicines has announced a research collaboration with the University of Pennsylvania (Penn) for the discovery and development of mRNA vaccines. The collaboration, under a sponsored research agreement, will focus on mRNA vaccines that can help in modulating the normal immune response of the body for the treatment of certain autoimmune diseases as well as allergic conditions.
Advertisement
There’s been a rapid shift towards decentralization in clinical trials & it’s clear why. The potential for reaching a larger pool of recruits is possible when sponsors can bring more trial activities to the patient. Tele visits, digital consent, new monitoring sensors, & direct-to-patient supply are virtual tools that existed before the pandemic, but now there’s swift adoption of these methods because they’ve been proven to help launch & complete trials more effectively.
Bio Pharma Dive
MARCH 20, 2023
As new gene therapies are developed to treat a growing number of indications, patients may soon have access to novel treatment options and potential cures.
Pharmaceutical Technology
MARCH 20, 2023
Pharma companies and world health stand to benefit from new technologies, but it’s a tough time to be an investor – and an even tougher one for firms seeking investment. From close to zero, central bank interest rates have risen to 3% in the Eurozone, 4% in the UK and nearly 5% in the USA. Further rate hikes could be on the way this year. For investors, dependable assets like government bonds have become a lot more tempting compared to volatile start-up shares.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
AuroBlog - Aurous Healthcare Clinical Trials blog
MARCH 20, 2023
Empowering of the Central Drugs Standard Control Organisation (CDSCO) through centralisation of drug licensing may not be the path to improve the quality of drugs manufactured in the country both for domestic and international markets, says SME Pharma Industries Confederation (SPIC), the apex organisation of small and medium pharma industries in the country.
Bio Pharma Dive
MARCH 20, 2023
The DNA-sequencing company said the activist investor hasn’t offered any better solutions for satisfying regulators’ concerns about the acquisition.
Deltaclinical
MARCH 20, 2023
With 20+ years of experience in clinical trials, Telemedicine Technologies is not only a recognised eClinical software editor but also an experienced Data Management service provider. With its CleanWeb® eClinical Suite, Telemedicine Technologies offers high-quality focused, flexible and cost-effective solutions that are dedicated to the electronic management of clinical trials and registries.
Pharmaceutical Technology
MARCH 20, 2023
Africa has considerable advantages and opportunities for trialling investigational medicinal products that, if pharma companies can correctly harness, will turn the continent into a superpower for clinical trials. Across 54 countries, the continent accounts for approximately 17% of the global population, and the total number of people living there is projected to surpass two billion within the next five years.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Bio Pharma Dive
MARCH 20, 2023
Speeding up the drug development process through a less optimized containment and delivery system may have been an option in the past, but both expectations and the competitive environment are changing.
Pharmaceutical Technology
MARCH 20, 2023
The race for a first-to-market therapy in non-alcoholic steatohepatitis (NASH) has been a marathon, with many companies facing numerous setbacks and failures. However, it appears that two companies have gained momentum and are in a sprint to the finish line. Leading the race to commercialisation is Intercept Pharmaceuticals, which, in December 2022, resubmitted the new drug application (NDA) for its obeticholic acid (OCA), an FXR agonist, as a Class 2 resubmission (which has a six-month review p
STAT News
MARCH 20, 2023
This is part of a series about new obesity drugs that are transforming patients’ lives, dividing medical experts, and spurring one of the biggest business battles in years. Read more about The Obesity Revolution. The rise of childhood obesity in the United States did not happen quickly. But, to medicine, “it sort of cropped up overnight,” says Bob Siegel, a pediatric obesity specialist at Cincinnati Children’s.
Pharmaceutical Technology
MARCH 20, 2023
Predictive Oncology and Cancer Research Horizons, a part of Cancer Research UK (CRUK), has collaborated to drive cancer drug development using the former’s PEDAL platform. The partnership will use the artificial intelligence (AI) and machine learning platform, PEDAL technology, to determine which cancer types and patient populations are most likely to respond to treatment with Cancer Research Horizon’s pre-clinical drug inhibitors of glutaminase.
Advertiser: FourKites
A research study conducted by The Journal of Commerce and FourKites surveyed hundreds of international shippers, exploring how their usage of global supply chain visibility technology has evolved since the onset of global disruptions caused by COVID-19. For international shippers, ocean freight visibility has evolved from optional to essential and satisfaction with visibility varies greatly depending on how it is obtained and delivered.
STAT News
MARCH 20, 2023
In the emergency room today, everyone is suffering. Many emergency medicine physicians are struggling to provide quality care amid staffing shortages, increased pressure to meet productivity metrics, and frustrated patients battling prolonged wait times. Their situation is compounded by a sense that they have been abandoned by hospital leadership, leading to increasing levels of physician burnout and attrition.
NPR Health - Shots
MARCH 20, 2023
If you're in your 20s, 30s or 40s, you need to know the signs to watch for and when to seek screening or treatment for colorectal cancer.
STAT News
MARCH 20, 2023
Renee Wegrzyn has been assembling teams her whole career — in academia, industry, and government. Now she’s in charge of a multibillion-dollar operation tasked with spotting talent, incubating breakthroughs, and doing for the life sciences what DARPA did for technology. Wegrzyn is director of the Advanced Research Projects Agency for Health , or ARPA-H, a newly formed organization tasked with investing in promising ideas across the life sciences.
NPR Health - Shots
MARCH 20, 2023
Cases of the fungus that did not respond to antifungal medicine tripled in 2021. It can be deadly, but does not seem to have adverse effects on healthy people.
Speaker: Steve Goldstein, Sales Leader
Are you currently in sales, or involved in a business that depends on strong sales results? What about the extremely competitive world of medical device sales? What are some of the top challenges your customers face and how do you approach understanding what’s most important to them? Join Steve Goldstein, Sales Success Coach, Motivational Speaker and Medical Device Sales Leader from Gold Selling LLC., to discover critical strategies and approaches you can take to engage your customers, achieve g
STAT News
MARCH 20, 2023
An AI medical scribe platform is the latest entrant into the AI arms race. On Monday, Microsoft-owned Nuance Communications announced it is integrating GPT-4 into its Dragon Ambient Intelligence platform, which is used by hospitals around the country to ease doctor workloads by using AI to listen to patient–provider conversations and write medical visit notes.
Medical Xpress
MARCH 20, 2023
A new technique that combines highly detailed, real-time images of inside the body with a type of infrared light has, for the first time, been used during surgery to differentiate between cancerous tumors and healthy tissue.
STAT News
MARCH 20, 2023
WASHINGTON — A Pentagon study has found high rates of cancer among military pilots and for the first time has shown that ground crews who fuel, maintain, and launch those aircraft are also getting sick. The data had long been sought by retired military aviators who have raised alarms for years about the number of air and ground crew members they knew who had cancer.
Medical Xpress
MARCH 20, 2023
It is recognized that low fruit and vegetable consumption is a major, modifiable, risk factor associated with raised blood pressure. However, how the national supply of fruit and vegetables has impacted blood pressure trends is little-known.
Advertiser: Aggregage
New vaccine mandates and testing policies will affect employers with more than 100 workers. Get Paycor’s free, customizable vaccination policy template to communicate critical details and new requirements to your employees. Get Paycor’s Template today!
STAT News
MARCH 20, 2023
DALLAS — A top Food and Drug Administration official said Monday that the agency needs to start using accelerated approval , a much-debated path commonly used for advancing cancer drugs, to advance gene therapies for rare disease. “We always are going to keep safety, front and foremost,” Peter Marks, head of the Center for Biologics Evaluation and Research, told attendees at the annual meeting of the Muscular Dystrophy Association.
Medical Xpress
MARCH 20, 2023
Almost all countries around the globe criminalize abortion in some circumstances, despite the public health risks and impact on human rights, finds a review of the scope of penalties for the procedure in 182 nations, published in the open access journal BMJ Global Health.
STAT News
MARCH 20, 2023
Karuna Therapeutics said Monday that its treatment for schizophrenia reduced psychosis reported by patients — achieving the main goal of a large clinical trial and supporting similarly positive results from previously conducted studies. The company intends to file a marketing application for its drug, called KarXT, with the Food and Drug Administration by the middle of the year.
Medical Xpress
MARCH 20, 2023
In January 2022, around the time that the omicron variant of SARS-CoV-2 started spreading rapidly, a team of researchers at the Indian Institute of Science (IISc) led by Shashank Tripathi, Assistant Professor at the Department of Microbiology & Cell Biology, and Centre for Infectious Diseases Research, noticed that there was an unusually high increase in the number of recombinant strains of the omicron variant.
STAT News
MARCH 20, 2023
Hospitals’ financial situations are not nearly as dire as industry groups are making them out to be, Medicare policy experts are telling Congress. Profit margins hit all-time highs in 2021, and almost $200 billion of taxpayer subsidies provided hospitals with ample cushion to get through the worst of the pandemic, the Medicare Payment Advisory Commission said in its newest report.
Medical Xpress
MARCH 20, 2023
Cancer treatment routinely involves taking out lymph nodes near the tumor in case they contain metastatic cancer cells. But new findings from a clinical trial by researchers at UC San Francisco and Gladstone Institutes shows that immunotherapy can activate tumor-fighting T cells in nearby lymph nodes.
STAT News
MARCH 20, 2023
When testing new treatments, drugmakers must show that their formulation bears out better results than a placebo in clinical trials. In fact, the new drug must outperform the placebo by a statistically significant margin using a measurement called “p-value.” In this short video, STAT national biotech reporter Damian Garde explains what p-value is, how it is used, and why it is still considered the gold standard for statistical significance , despite its shortcomings.
Medical Xpress
MARCH 20, 2023
Nearly half of parents say they would definitely know if their child was vaping, despite characteristics of vaping devices that make it easy to hide or disguise their use, a new national poll suggests.
STAT News
MARCH 20, 2023
Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that oh-so familiar routine of phone calls, online meetings, and deadlines has returned. To cope, we are firing up the coffee kettle and brewing a few cups of stimulation. Our choice today is chocolate marshmallow, for those tracking this sort of thing.
Antidote
MARCH 20, 2023
Hepatitis B , sometimes abbreviated to HBV, is a liver infection that is one of the most serious in the world. If left untreated, hepatitis B can cause fibrosis, cirrhosis, hepatocellular carcinoma, and end-stage liver disease.
Expert insights. Personalized for you.
294 
Let's personalize your content